Merck & Co., Inc. (BVMF:MRCK34)

Merck & Co. Statistics

Total Valuation

Merck & Co. has a market cap or net worth of BRL 1.58 trillion. The enterprise value is 1.70 trillion.

Market Cap	1.58T
Enterprise Value	1.70T

Important Dates

The last earnings date was Tuesday, February 3, 2026.

Earnings Date	Feb 3, 2026
Ex-Dividend Date	Dec 12, 2025

Share Statistics

Current Share Class	n/a
Shares Outstanding	n/a
Shares Change (YoY)	-1.34%
Shares Change (QoQ)	-0.40%
Owned by Insiders (%)	0.05%
Owned by Institutions (%)	78.90%
Float	2.48B

Valuation Ratios

The trailing PE ratio is 15.71 and the forward PE ratio is 23.64.

PE Ratio	15.71
Forward PE	23.64
PS Ratio	4.41
PB Ratio	5.52
P/TBV Ratio	19.18
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	16.92
EV / Sales	5.01
EV / EBITDA	11.32
EV / EBIT	13.30
EV / FCF	n/a

Financial Position

Current Ratio	n/a
Quick Ratio	n/a
Debt / Equity	0.80
Debt / EBITDA	1.44
Debt / FCF	n/a
Interest Coverage	18.06

Financial Efficiency

Return on equity (ROE) is 37.17% and return on invested capital (ROIC) is 28.30%.

Return on Equity (ROE)	37.17%
Return on Assets (ROA)	n/a
Return on Invested Capital (ROIC)	28.30%
Return on Capital Employed (ROCE)	n/a
Weighted Average Cost of Capital (WACC)	5.50%
Revenue Per Employee	4.84M
Profits Per Employee	1.36M
Employee Count	75,000
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

In the past 12 months, Merck & Co. has paid 15.44 billion in taxes.

Income Tax	15.44B
Effective Tax Rate	13.31%

Stock Price Statistics

The stock price has increased by +20.64% in the last 52 weeks. The beta is 0.30, so Merck & Co.'s price volatility has been lower than the market average.

Beta (5Y)	0.30
52-Week Price Change	+20.64%
50-Day Moving Average	71.39
200-Day Moving Average	60.36
Relative Strength Index (RSI)	69.51
Average Volume (20 Days)	3,895

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	2.28

Income Statement

In the last 12 months, Merck & Co. had revenue of BRL 358.08 billion and earned 100.54 billion in profits. Earnings per share was 40.10.

Revenue	358.08B
Gross Profit	276.02B
Operating Income	134.97B
Pretax Income	116.04B
Net Income	100.54B
EBITDA	158.62B
EBIT	134.97B
Earnings Per Share (EPS)	40.10

Balance Sheet

The company has 100.32 billion in cash and 227.89 billion in debt, with a net cash position of -127.57 billion.

Cash & Cash Equivalents	100.32B
Total Debt	227.89B
Net Cash	-127.57B
Net Cash Per Share	n/a
Equity (Book Value)	285.90B
Book Value Per Share	114.82
Working Capital	n/a

Cash Flow

Operating Cash Flow	n/a
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Margins

Gross margin is 77.08%, with operating and profit margins of 37.69% and 28.08%.

Gross Margin	77.08%
Operating Margin	37.69%
Pretax Margin	32.41%
Profit Margin	28.08%
EBITDA Margin	44.30%
EBIT Margin	37.69%
FCF Margin	n/a

Dividends & Yields

This stock pays an annual dividend of 1.53, which amounts to a dividend yield of 1.95%.

Dividend Per Share	1.53
Dividend Yield	1.95%
Dividend Growth (YoY)	5.07%
Years of Dividend Growth	3
Payout Ratio	n/a
Buyback Yield	1.34%
Shareholder Yield	3.29%
Earnings Yield	6.37%
FCF Yield	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

The last stock split was on October 29, 2020. It was a forward split with a ratio of 8.

Last Split Date	Oct 29, 2020
Split Type	Forward
Split Ratio	8

Scores

Altman Z-Score	n/a
Piotroski F-Score	1